L
Lorenz Trümper
Researcher at University of Göttingen
Publications - 276
Citations - 22696
Lorenz Trümper is an academic researcher from University of Göttingen. The author has contributed to research in topics: Lymphoma & Diffuse large B-cell lymphoma. The author has an hindex of 53, co-authored 260 publications receiving 19534 citations. Previous affiliations of Lorenz Trümper include Deutsche Forschungsgemeinschaft & University of Cologne.
Papers
More filters
Journal ArticleDOI
[Mesenchymal stem cells from bone marrow. Phenotype, aspects of biology, and clinical perspectives].
TL;DR: Further preclinical studies as well as clinical cell therapy studies are essential to fully exploit the potential of mesenchymal stem cells in regenerative medicine, cellular immunotherapy, and gene therapy.
Journal ArticleDOI
B-cell chronic lymphocytic leukemia with aberrant CD8 expression: Genetic and immunophenotypic analysis of prognostic factors
Roland Schroers,Tobias Pukrop,Jan Dürig,Detlef Haase,Ulrich Dührsen,Lorenz Trümper,Frank Griesinger +6 more
TL;DR: The determined profile of prognostic markers together with the highly stable and indolent disease in the described patient suggest a good prognosis of B-CLL with aberrant CD8 expression.
Journal ArticleDOI
Secondary leukaemia after cure for locally advanced NSCLC: Alkylating type secondary leukaemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB
TL;DR: This is the first report in the literature of t-MDS after docetaxel chemo-radiotherapy, implicating a possible association of docetAXel with alkylator type t- MDS and t-AML.
Journal ArticleDOI
Radioimmunotherapy Confers Long-Term Survival to Lymphoma Patients with Acceptable Toxicity: Registry Analysis by the International Radioimmunotherapy Network
Karin Hohloch,Angelika Bischof Delaloye,Christiane Windemuth-Kieselbach,Jose Gómez-Codina,Werner Linkesch,Woijciech Jurczak,Roberto Cacchione,Cheolwon Suh,Pier Luigi Zinzani,Lorenz Trümper +9 more
TL;DR: This analysis proves that radioimmunotherapy in follicular lymphoma and other lymphoma subtypes is a safe and efficient treatment option and can be assessed by this registry, enabling analyses of outcome and toxicity data beyond clinical trials.
Journal ArticleDOI
Molecular cytogenetic monitoring from CD34+ peripheral blood cells in myelodysplastic syndromes: First results from a prospective multicenter German diagnostic study
Friederike Braulke,Klaus Jung,Julie Schanz,Katharina Götze,Catharina Müller-Thomas,Uwe Platzbecker,Ulrich Germing,Tim H. Brümmendorf,Gesine Bug,Oliver G. Ottmann,Aristoteles Giagounidis,Michael B. Stadler,Wolf-Karsten Hofmann,Philippe Schafhausen,Michael Lübbert,Richard F. Schlenk,Igor Wolfgang Blau,Christina Ganster,Sebastian Pfeiffer,Katayoon Shirneshan,Michael Metz,Sven Detken,Jörg Seraphin,Kathleen Jentsch-Ullrich,Angelika Böhme,Burkhard Schmidt,Lorenz Trümper,Detlef Haase +27 more
TL;DR: It is demonstrated that CD34+ PB FISH correlates significantly with CCB analysis and represents a feasible method for a reliable non-invasive cytogenetic monitoring from PB.